Project Year 2018
Dietary protein-to-lipid ratio
Scientist Jens-Erik Dessen has studied what farmed salmon should eat in order to optimize growth and health.
Simplified, fish farmers want to get the most out of their inputs – the fish and feed. However, fish farming is influenced by environmental conditions, operating form, smolt quality and infectious deseases – all of which vary widely.
This was the starting point for Jens-Erik Dessen’s PhD work, under the supervision of Professor Kjell-Arne Rørvik, which included trials in pens in three very different farming locations along the Norwegian coast.
How protein and fat affects growth
“The experiments lasted up to a year and a half, in order to identify important connections, giving us unique insight into how variables in the environment, feed and fish affect the production,” says Dessen.
He has studied at how the protein and fat content in the feed affects growth, feed utilization, health, quality and fat deposition in farmed salmon. This was done to identify good balances in the dietary protein-to-lipid ratio related to different seasons and periods with high risk of viral diseases (pancreas disease).
He has performed four studies in his PhD and has three general recommendations:
– Smolt transferred to sea in spring require high dietary energy and high protein content during the early seawater phase for optimal growth performance.
– Increased dietary protein-to-lipid ratio could be utilized during the first spring and summer in sea for sites with high risk of pancreas disease outbreaks to improve survival and reduce the accumulation of severely thin diseased fish (runts).
– High fat content in the fish, especially in early autumn, reduces the long-term growth potential.
The trials were performed in small-scale at Averøy Research Station and in large-scale at Nofima’s research facilities in southern, central and northern Norway. This was done in order to ensure research that could be of practical relevance for the fish farming industry.
IN COOPERATION WITH:
Blom fiskeoppdrett AS, Nordlaks oppdrett AS, Lerøy Midt and BioMar
Nofima. The small-scale trials were partly funded by the Fishery and Aquaculture Industry Research Fund (FHF) and Havsbrún